A potential COVID-19 vaccine is still hypothetical – several vaccines are now on a test.
As the COVID-19 outbreak continues to escalate – more and more researchers are finding a potential vaccine. Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine. The World Health Organization (WHO) also said that they did not expect a vaccine against COVID-19 to become available in less than 18 months.
But by April 2020, at least 50 vaccine candidates were in development. One of which is a vaccine that may cost as low as $1, a study published on Friday (10 April 2020) in the Journal of Virus Eradication.
According to Andrew Hill, a senior research fellow in the pharmacology department at Liverpool University and a co-author of the study, if the drugs show promise, there is a potential to massively scale up production and provide low-cost generic supplies worldwide.
“At these low prices, anyone needing treatment for coronavirus, in any country, should be able to access the treatment they need,” Hill stated in an email.
“We urgently need worldwide access to effective antiviral treatments for coronavirus to hold back the epidemic for the next 18 months until a vaccine can be produced. We already know how to mass-produce and distribute low-cost drugs to treat HIV, tuberculosis and malaria. It is time to repeat these success stories for coronavirus, but this time much more quickly,” added Hill.